Get in Touch

Global Partners LP Raises Over $65,000 for Cure Rare Disease

Fueling groundbreaking development of precision medicine therapeutics to treat Duchenne muscular dystrophy and more.
Key Takeaways
  • GP raised over $65,000 for Cure Rare Disease (CRD), a Boston-based non-profit organization committed to the development of precision medicine therapeutics that combat select rare diseases impacting millions of people nationwide.
  • Four-week program included $1 ask and cashbox collection campaign at approximately 300 local stores.
  • Founder of CRD, Rich Horgan, is a local entrepreneur who aims to save his brother Terry, who has been battling against DMD, plus thousands of others.

BOSTON, MA, (October 21, 2019)—Global Partners LP, a third-generation family-founded business, operating one of the largest networks of gas stations and convenience stores in the Northeast, announced today that it raised over $65,000 for Cure Rare Disease (CRD), a Boston-based non-profit organization committed to the development of precision medicine therapeutics that combat select rare diseases impacting millions of people nationwide.

Global Partners facilitated a giving program for four weeks in August with a $1 ask and cashbox collection campaign at approximately 300 local stores, including their Xtramart, Honey Farms and Alltown brands. Global’s success matches national trends. According to the National Philanthropic Trust, overall corporate giving in 2018 increased to more than $20B—a 5.4% jump from 2017.

CRD has assembled leading researchers and clinicians nationwide to develop precision medicine therapeutics for rare, genetic, and fatal diseases like Duchenne muscular dystrophy (DMD), one of 8 designated rare diseases that the non-profit is focusing on today. The organization and its multidisciplinary approach to developing customized treatments has been inspired by the personal experience of Founder & President, Rich Horgan. Horgan is a 27-year old Cornell and Harvard MBA graduate—an emerging entrepreneur with a passion to drive tangible transformation in the healthcare space. His family, including his brother Terry, has been impacted by Duchenne muscular dystrophy for three generations. 

We are honored to support Cure Rare Disease with our recent fundraising program,” said Joanna Linder, vice president of marketing at Global Partners. “With millions of people impacted by more than 7,000 rare diseases, our goal is to continue to fund their transformational solutions, inspiring both awareness and hope. We’re committed to supporting the communities where we live and work and look forward to continuing this partnership in 2020.Global is looking forward to developing a roadmap for their 2020 campaign, given the positive results from 2019.

“I deeply appreciate the support of Global Partners, a community-minded company who truly wants to support transformational developments such as ours. I founded CRD in response to the disappointing lack of therapies and feasible treatments for my brother, Terry, and millions of others who suffer from the wide variance of genetic diseases,” remarked Rich Horgan, Founder & President of Cure Rare Disease. “Our mission is to pioneer customized therapeutic developments in record time, thanks to our stellar team of researchers, partners, and our donors.  Every single dollar counts, and partnerships with organizations like Global Partners propels us closer to a cure.”

 To learn more or get involved, visit http://cureraredisease.org.

About Cure Rare Disease

Cure Rare Disease (CRD) is a Boston-based nonprofit biotechnology company founded by Rich Horgan, Blavatnik Life Science Entrepreneur-in-Residence at Harvard Business School who has witnessed three generations of his family affected by Duchenne muscular dystrophy, a fatal, neuromuscular disease. As anyone who is touched by a fatal, rare disease knows, time is of the essence. To overcome the obstacles inherent in the existing model of drug development, CRD has taken a new approach, forming an unprecedented collaboration with leading researchers and institutions nationwide in genetics, genomics, bioinformatics and biotechnology. Horgan and team are pioneering the development of a new platform for customized therapeutic treatments that can be applied to a range of rare, genetic diseases, and aim to inspire hope for a cure. Learn more at www.cureraredisease.org.


About Global Partners

Global Partners delivers the energy, goods and services that make life better. With an extensive network of terminals, gas stations and convenience stores, Global helps people heat their homes, operate their businesses and get where they’re going conveniently and quickly. Centered in the Northeast, the company is a third-generation, family-founded business with operations throughout the U.S. Global is committed to strategic growth and to supporting the communities where it works. Learn more at www.globalp.com

Key Takeaways
  • GP raised over $65,000 for Cure Rare Disease (CRD), a Boston-based non-profit organization committed to the development of precision medicine therapeutics that combat select rare diseases impacting millions of people nationwide.
  • Four-week program included $1 ask and cashbox collection campaign at approximately 300 local stores.
  • Founder of CRD, Rich Horgan, is a local entrepreneur who aims to save his brother Terry, who has been battling against DMD, plus thousands of others.
Media Gallery
Quotes
We are honored to support Cure Rare Disease with our recent fundraising program. With millions of people impacted by more than 7,000 rare diseases,...
Joanna LinderVice President of Marketing, Global Partners LP
I deeply appreciate the support of Global Partners, a community-minded company who truly wants to support transformational developments such as our...
Rich HorganFounder & President, CRD
Our mission is to pioneer customized therapeutic developments in record time, thanks to our stellar team of researchers, partners, and our donors. ...
Rich HorganFounder & President, CRD
Related Bios
Rich Horgan
Founder & President
View Full Bio>>
Contacts
Nina Pfister
nina@mooringadvisorygroup.com
781-929-5620
Media Contact
Lauren Gill
lauren@mooringadvisorygroup.com
978-473-1362
Media Contact